HomeCompareNDVLY vs PFE

NDVLY vs PFE: Dividend Comparison 2026

NDVLY yields 26.00% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PFE wins by $24.1K in total portfolio value· pulled ahead in Year 9
10 years
NDVLY
NDVLY
● Live price
26.00%
Share price
$0.50
Annual div
$0.13
5Y div CAGR
-45.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.4K
Annual income
$7.49
Full NDVLY calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — NDVLY vs PFE

📍 PFE pulled ahead of the other in Year 9

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNDVLYPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NDVLY + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NDVLY pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NDVLY
Annual income on $10K today (after 15% tax)
$2,210.00/yr
After 10yr DRIP, annual income (after tax)
$6.37/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, PFE beats the other by $22,313.54/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NDVLY + PFE for your $10,000?

NDVLY: 50%PFE: 50%
100% PFE50/50100% NDVLY
Portfolio after 10yr
$37.5K
Annual income
$13,133.10/yr
Blended yield
35.03%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

NDVLY
No analyst data
Altman Z
0.5
Piotroski
3/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NDVLY buys
0
PFE buys
0
No recent congressional trades found for NDVLY or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNDVLYPFE
Forward yield26.00%6.13%
Annual dividend / share$0.13$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-45.7%13.2%
Portfolio after 10y$25.4K$49.6K
Annual income after 10y$7.49$26,258.71
Total dividends collected$3.4K$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: NDVLY vs PFE ($10,000, DRIP)

YearNDVLY PortfolioNDVLY Income/yrPFE PortfolioPFE Income/yrGap
1$12,112$1,411.80$9,153$693.39+$3.0KNDVLY
2$13,827$867.76$8,593$849.25+$5.2KNDVLY
3$15,298$502.74$8,336$1,066.78+$7.0KNDVLY
4$16,651$282.27$8,437$1,384.80+$8.2KNDVLY
5$17,973$155.91$9,013$1,875.40+$9.0KNDVLY
6$19,316$85.40$10,306$2,680.72+$9.0KNDVLY
7$20,715$46.58$12,820$4,101.38+$7.9KNDVLY
8$22,190$25.35$17,673$6,826.70+$4.5KNDVLY
9← crossover$23,757$13.78$27,543$12,591.86$3.8KPFE
10$25,428$7.49$49,560$26,258.71$24.1KPFE

NDVLY vs PFE: Complete Analysis 2026

NDVLYStock

New World Development Company Limited, an investment holding company, engages in the property development and investment business in Hong Kong and internationally. Its property portfolio comprises residential, retail, office, and industrial properties. The company also provides commercial aircraft leasing services; operates expressways; and constructs residential and commercial projects, as well as provides protection and savings-related life and medical insurance products. In addition, it is involved in the duty-free operation and general trading, civil engineering, loyalty program, marketing, promotion, fashion retailing and trading, and piling and ground investigation businesses; development and operation of sports park; operation of household goods shop and convenience store; sale of LED lighting products and systems; and trading of telecommunication system integration products. Further, the company manages Hong Kong Convention and Exhibition Centre; operates hotels, golf and tennis academies, and shopping malls; operates department stores; and provides information technology, healthcare, training course, ticketing, financial, project management, management, advertising and media related, business and investment consultancy, franchised and non-franchised bus, estate agency, wellness and rehabilitation, endoscopic, carpark management, supply chain management, and catering services, as well as property agency, management, and consultancy services. Additionally, the company undertakes façade and foundation works; and offers elderly residential and nursing care services. As of June 30, 2021, the company had a total of 18 hotel properties with approximately 7,503 rooms in Hong Kong, Mainland China, and the Southeast Asia. New World Development Company Limited was founded in 1970 and is headquartered in Central, Hong Kong.

Full NDVLY Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this NDVLY vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NDVLY vs SCHDNDVLY vs JEPINDVLY vs ONDVLY vs KONDVLY vs MAINNDVLY vs JNJNDVLY vs MRKNDVLY vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.